AiMorphous Health
About
At AiMorphous Health, we are leveraging a novel dual-component system that combines early blood biomarkers with a proprietary algorithm, we are the first mover in the market addressing the limitations in early detection and predictive accuracy that hinder current thrombosis care standards. Our validated biomarkers exhibit exceptional sensitivity and specificity, driving a risk model that delivers high-resolution, personalized risk assessments with unprecedented precision.
At AiMorphous Health, our mission is to safeguard the wellbeing of everyone living with risk through intelligent and remote monitoring through breakthrough technology. In addition, our innovation with add value to the whole ecosystem in the healthcare.